Plasma lead (Pb) levels have been measured in normal and lead-intoxicated children, newborns, and children with sickle cell disease. The results in all groups were contant over a wide range of red cell Pb concentration. These results support the thesis that the red cell represents a large repository for Pb, maintaining plasma Pb concentration within closely defined limits, and that methods other than measurements of plasma Pb will be necessary to uncover a presumably dynamic transport system between red cell and plasma. Indeed, we have demonstrated in vitro that ionized calcium (Ca2+) lowers red cell Pb content according to a linear dose-response curve.
plasma Pb has been summarized as varying from 0 to less than 5 jlg/100 ml in leadintoxicated children (1) (2) (3) , though the specific data supporting the latter statement have rarely, if ever, been published. Recently, McIntyre and Angle (4), on the basis of theoretical regression lines, have estimated Pb concentration in serum (or plasma) of a magnitude several times greater than previous estimates. In addition, these authors indicated that serum Pb levels were lower in anemic children deficient in glucose-6-phosphate dehydrogenase compared to nondeficient children. To examine the usefulness of Pb levels in plasma as an indicator of Pb metabolism, and to evaluate possible differences in the partition of Pb in low and high hematocrit blood, we have measured directly plasma Pb levels in 165 children.
Measurements of lead were carried out on (Table 1) (6) . No significant statistical difference in these plasma values could be established for children with sickle cell disease, lead intoxication, or for newborns, when compared to normal children (Table 2 ). In brief, similar to an earlier study of adult human blood in vitro (7), these data indicate that levels of lead in plasma remain constant in the face of wide differences in the concentration of lead in red blood cells. Though these results have agreed, generally, with two preceding reports, very few subjects previously reported fell within the pediatric age group; and none of these had either symptomatic Pb intoxication and/or sickle cell disease (2, 3) .
These observations have provided further support for the hypothesis that the red cell represents a rich repository for Pb (8) , maintaining plasma Pb levels within very closely defined limits. It may well be that only a small fraction of lead in plasma is in a physiologically active form; and total plasma lead would exhibit very small changes, not detected even by this sensitive nonflame atomic absorption method, as blood lead rises. Our own studies of normal adult plasma have indicated that a relatively small, but demonstrable amount of total plasma lead can be ultrafiltered through a membrane with a molecular weight cut-off of 2000 (Rosen and Trinidad, unpublished observations). It appears, therefore, that the binding capacity of red cell receptors for lead may be relatively unlimited, at least within the range of blood Pb values reported herein. Accordingly, correction of whole blood Pb levels for hematocrit appears not to he warranted. Thus, recalculation of whole blood Pb levels for hematocrit fails to provide a more precise index of Pb toicity, and fails to reflect the likely biochemical realities involved in the partition of Pb in whole blood. Our data are consistent with the postulate that phosphate (7) and perhaps other binding sites (9-11) of red cells are critical biochemical factors in the partition of lead in blood-not red cell mass per se; dynamic methods (12) , other than an isolated measurement of plasma Pb, will likely be necessary to uncover mechanisms of lead transport between red cell, plasma, soft, and hard tissues.
Indeed, we have demonstrated now in vitro that ionized calcium (Ca ), at a concentration of 4 mg/100 ml or greater, displaces lead from "leaded" rat erythrocytes according to a linear dose response curve ( Fig. 1 ) (12) . In this system, red cells were collected from lead-intoxicated rats, washed, and suspended in a Ca2+-free chemically defined medium at pH 7. was measured by an ion-specific electrode, 210Pb was counted on an auto-gamma spectrometer, and stable Pb was measured on the CRA.
After incubation with Ca2+ in final concentrations of 0, 2, 4, 6, and 8 mg/100 ml, red cell Pb decreased by 0, 0, 12, 24, and 40%o, respectively (Fig. 1) . These highly significant decreases in red cell Pb, only above a threshold concentration of 4 mg/100 ml, were complete within 30 min (refer to Fig. 2 for description of in vitro red cell system). Experiments with 21'Pb yielded similar results. Furthermore, Zn2+, Cu2+, and Mg2+, up to 1.00, 1.00, and 2.5mM, respectively, had no effect on the concentration of red cell Pb. Environmental Health Perspectives salt at pH 7.40, had no effect on red cell lead content in this system (Rosen and Trinidad, unpublished observations.) These data suggest, therefore, that Ca2+ may control Pb transport from red cell to plasma; and changes in the concentration of Ca2+ in serum and extracellular fluid may influence both the dynamics of Pb transport and the toxic activities of Pb. The in vivo correlates of these in vitro observations are notable (13) (14) (15) (16) . In leadintoxicated rats, challenge with Ca2+, above a specific concentration threshold comparable to the one in vitro, produces a rapid decrease in red cell Pb content; this effect is maintained after levels of Ca2+ in serum return to baseline values. Moreover, similar to the in vitro system, below an initial concentration of about 40 Mg/100 ml, a decrease in erythrocyte lead concentration cannot be demonstrated (17) . Furthermore, in six Pbintoxicated children, levels of ionized calcium in serum increased 1.50 mg/100 ml ±0.2 (mean ± S.E.M.) above baseline values, during chelation with EDTA (calcium disodium salt (Rosen and Trinidad, unpublished observations). These increases closely parallel the fall in blood Pb levels; and the return of Ca2+ in serum to baseline values coincides with an increase in blood Pb content shortly after the end of EDTA therapy. Hence, part of the observed EDTA effect in these children may be secondary to the effects of calcium ion administered with EDTA.
Bone
The skeleton is the ultimate reservoir for over 90%o of the human body burden of Pb.
In children, the factors that control Pb metabolism in bone are particularly critical, since bone represents the major source of Pb mobilized by EDTA. In addition, "subtoxic" amounts of Pb may be mobilized during the course of rapid skeletal growth in children, a process involving concurrently new bone formation and bone resorption. Presumably, the cardinal factors effecting bone mineral mobilization, namely, calcitonin, PTH, vitamin D metabolites, 3',5'-AMP, and the ionic composition of the extracellular fluid, control the efflux of Pb from bone.
We have begun recently to study the skeletal metabolism of Pb in bone organ culture. To increase the amount of stable Pb in fetal rat bones, pregnant rats are intoxicated with Pb throughout prgenancy by adding lead acetate to the drinking water. On the 17th day of gestation, 50 M,Ci of 210Pb in 2 mg of carrier Pb are injected IV into each pregnant rat. By the 18th day of gestation, blood Pb levels in the pregnant rats have reached 40-60 ,ug/100 ml. At this time, when paired radii and ulnae are dissected and "planted" on grids in modified BGJ medium, the amount of Pb in these fetal bones is four to six times that in normal fetal bones. After 2-4 days in culture, the radioactivity released from treated bones to the medium is compared to that released from paired control bones. 210Pb activity in the medium is measured in a liquid scintillation spectrometer. In these experiments, the concentrations of ions and protein in the medium have been modified to closely approximate those in the extracellular fluid (18) .
Early results in this system are (1) increasing the concentration of phosphate (1.0 to 5.0mM) or Ca2+ (1.5 to 3.00mM) produces a significant decrease in lead efflux of 60 and 24%o, respectively, in response to PTH (18); (2) changes in the concentration of Mg2+ in the medium have no effect on the efflux of 210Pb in response to PTH; (3) the magnitude in efflux of 210Pb from bones treated with PTH becomes considerably greater as the initial concentration of stable Pb rises. These results suggest that PTH and the ionic milieu of the medium (extracellular fluid) interact and exert considerable control on the release of previously incorporated 210Pb and that the initial concentration of stable Pb is critical in evaluating the magnitude in efflux of 210Pb from explant to medium. After an extensive number of Pb analyses of ashed bones, the concentration of stable Pb and the magnitude in efflux of 210Pb have become sufficiently reproducible now in control versus PTH-treated bones (Rosen and Trinidad, unpublished observations).
In summary, we expect that understanding further the dynamics of Pb transport in plasma and bone may lead to a more exact biological definition of the real and potential hazards of low level Pb toxicity in children.
